A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

This study has been completed.

Study NCT00085826 Information provided by OSI Pharmaceuticals

First Received: June 15, 2004 Last Updated: October 10, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2004
Estimated Primary Completion Date:	No date given